M H Lader. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Age FactorsAntipsychotic Agents/adverse effectsBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/physiopathologyBasal Ganglia Diseases/prevention & controlCentral Nervous System Stimulants/therapeutic useChildDiagnosis, DifferentialDose-Response Relationship, DrugDystonia Musculorum Deformans/chemically inducedDystonia Musculorum Deformans/diagnosisDystonia Musculorum Deformans/drug therapyDystonia Musculorum Deformans/physiopathologyDystonia Musculorum Deformans/prevention & controlFemaleHumansMaleMovement Disorders/chemically inducedMovement Disorders/prevention & controlParasympatholytics/therapeutic useParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/drug therapyParkinson Disease, Secondary/physiopathologyParkinson Disease, Secondary/prevention & controlPhenothiazinesSex FactorsTranquilizing Agents/adverse effects
Substances： See more » Antipsychotic AgentsCentral Nervous System StimulantsParasympatholyticsPhenothiazinesTranquilizing Agents
Year: 1970 PMID： 4150143 PMCID： PMC5366630
Source DB: PubMed Journal: J R Coll Physicians Lond ISSN： 0035-8819
Download PDF